In the microscopic world of sperm selection, a subtle motion might be the key to unlocking higher IVF success rates. Scientists have discovered that sperm exhibiting a unique corkscrew-like movement are not only more motile but also significantly more likely to produce high-quality embryos. This insight is reshaping how we approach sperm selection in assisted reproductive technology (ART).
The corkscrew motion isn’t just a quirky dance under the microscope—it’s a powerful biological signal.
What is the Corkscrew Motion?
Under normal conditions, sperm swim in a straightforward, sometimes erratic path. But when challenged with thicker fluids, like the high-viscosity environments used in a new technique called viscosity-gradient micropatterning, only a few sperm show a specialized, spiraling movement—dubbed the corkscrew motion.
This helical movement allows sperm to drill through thicker fluids, mimicking the conditions they would encounter in the female reproductive tract. The sperm that succeed in this microfluidic challenge aren’t just stronger—they’re smarter swimmers with better motility, morphology, and likely genetic health.
Why It Matters in IVF
In conventional ICSI procedures, sperm are chosen manually from a viscous PVP solution. But this new method layers media of different viscosities, forcing sperm to migrate inward through increasing resistance. Those that reach the center are selected for injection.
Interestingly, the sperm that make it through consistently exhibit the corkscrew motion. When these sperm were used in a recent study involving 108 patients, the outcomes improved dramatically:
Fertilization rates jumped to 93.9%
High-quality embryos on Day 3 rose to 89.1%
Day 5 blastocyst formation improved to 51.5%
This is no coincidence. The corkscrew swimmers are clearly doing something right.
Nature’s Filter, Now in the Lab
The corkscrew motion may be nature’s way of filtering out weaker sperm. In the human body, sperm must swim through cervical mucus and uterine fluids—natural high-viscosity environments. Only the fittest reach the egg.
By recreating these conditions in the lab, embryologists can now let physics and biology work together to select the best sperm. It’s a natural filter, redesigned for the Petri dish.
The Future of Fertility Treatment
The beauty of this technique lies in its simplicity. No new tools, no expensive machines—just a clever way of arranging the sperm’s environment to see who rises to the challenge. And with time savings of up to 85% in sperm selection, it’s also streamlining IVF workflows.
As this technique gains traction, we may start seeing the corkscrew motion as a new gold standard in sperm quality—a subtle spin that could bring big changes to fertility success stories worldwide.
In a major breakthrough for fertility science, researchers have developed a physics-based sperm selection technique that significantly improves IVF outcomes while slashing sperm selection time by up to 85%.
The new method, called viscosity-gradient micropatterning, uses layers of fluid with varying thickness to mimic natural sperm navigation. Only the strongest sperm—those that can cut through higher viscosity—make it to the central zone, revealing a unique corkscrew motion linked to higher quality.
Tested on 108 patients in a six-month study, the results were striking:
Fertilization rate: 93.9% (vs. 90.3%)
Day 3 embryo quality: 89.1% (vs. 81.8%)
Blastocyst formation: 51.5% (vs. 44%)
Best of all? The method requires no new equipment—just a smarter way to use what’s already in the lab.
“This could become a game-changer in IVF,” say researchers. Faster, cheaper, and more effective, it promises new hope for couples worldwide.
In the world of assisted reproductive technologies (ART), improving fertilization rates, embryo quality, and overall in vitro fertilization (IVF) outcomes is an ongoing challenge. Recent innovations continue to push the boundaries of what’s possible, and one such breakthrough lies in the optimization of sperm selection during Intracytoplasmic Sperm Injection (ICSI). A recent study investigates the impact of a viscosity-gradient micropatterning technique, an advanced physics-driven microfluidic pathway designed to improve sperm filtration, thus enhancing ART outcomes. But how does it work, and what makes this method so revolutionary?
Understanding the Traditional ICSI Process
ICSI, one of the most common and advanced forms of IVF, involves selecting a single sperm and injecting it directly into an oocyte. Traditionally, sperm are selected using a polyvinylpyrrolidone (PVP) streak in the dish. The sperm selection process, however, is time-consuming and can be challenging, particularly when it comes to determining sperm quality. Moreover, prolonged exposure of sperm and oocytes in the ICSI dish can increase the risk of potential harm to the gametes, including epigenetic changes.
Over the years, researchers have explored various methods to optimize sperm selection, such as Physiological ICSI (PICSI), which uses chemotaxis, and Magnetic Assisted Cell Sorting (MACS), which utilizes magnetic fields to isolate sperm with better DNA integrity. But a new technique, the viscosity-gradient micropatterning approach, aims to address these issues and enhance the ICSI process even further.
The Concept: Viscosity-Gradient Micropatterning
This groundbreaking technique leverages the physics of viscosity gradients to create a selective environment for sperm. The process uses layers of varying PVP concentrations, with each layer exhibiting different viscosities. Sperm are loaded into the outermost layer, and the theory is simple: sperm with the ability to migrate through higher viscosity zones exhibit superior motility and morphology.
The key finding is that sperm that can effectively move from a low-viscosity environment to a higher-viscosity region demonstrate a unique corkscrew motility pattern, which is correlated with better sperm quality. This makes them ideal candidates for injection into oocytes.
In contrast to conventional sperm selection methods, this technique not only allows for a more efficient sperm selection process but also significantly reduces the time spent selecting sperm, improving overall workflow in ART labs.
The Study: Methodology and Results
Study Design and Participants
This study was conducted over six months and involved 108 routine patients. Each patient’s oocytes were divided into two groups: one group underwent traditional sperm selection, while the other used the viscosity-gradient micropatterning technique. The embryos resulting from each group were then observed and compared.
Experimental Setup
The micropatterning process involved creating concentric circles of reducing PVP gradients around a central PVP streak. These circles were connected by bridges, and sperm were loaded into the outermost layer. After incubation, sperm were checked at five-minute intervals to determine which sperm migrated to the central streak—these were selected for ICSI.
Key Findings
The results were impressive:
Fertilization Rate: The fertilization rate for the viscosity-gradient method improved from 90.3% to 93.9%.
Embryo Quality: The percentage of high-quality Day 3 embryos (Grade A+ and Grade B) increased from 81.8% to 89.1%.
Blastocyst Formation: Day 5 blastocyst formation rates rose from 44% to 51.5%.
Furthermore, the sperm selection time was reduced by 80–85%, dramatically optimizing the workflow of embryologists and increasing the efficiency of the entire ART process.
Significance of the Findings
These findings offer exciting implications for the future of ART. The most noteworthy aspect of this study is the corkscrew motility pattern observed in the selected sperm. Sperm exhibiting this unique motion were better able to traverse the higher viscosity zones, an indicator of their superior motility and overall quality. This suggests that using the viscosity-gradient micropatterning technique could help select sperm that have the highest chance of successful fertilization, leading to improved embryo development and IVF success.
Moreover, by reducing sperm selection time, the technique offers significant practical benefits for embryologists, allowing for a faster, more efficient workflow in the laboratory.
Limitations and Considerations
While the results of this study are promising, it’s essential to consider some limitations. The miscible nature of the viscosity gradients necessitates a strict timeline for sperm selection. If the selection process takes too long, the gradients could blend, compromising the method’s effectiveness.
Additionally, the study was conducted in vitro, meaning that further clinical validation is required to confirm whether these results can be reproduced in real-world clinical settings across diverse patient populations.
Wider Implications for ART
The viscosity-gradient micropatterning technique represents a cost-effective, real-time, and easily integrable solution for ICSI. Importantly, it does not require any additional consumables or equipment beyond what is already used in conventional ICSI procedures. This makes it an attractive option for ART centers globally, as it has the potential to improve embryo quality and success rates without incurring significant additional costs.
By optimizing sperm selection and reducing procedural times, this method could make a substantial global impact on fertility treatments, especially in areas where ART resources may be limited or where affordability is a key concern.
Conclusion: A Promising Future for Fertility Treatments
The viscosity-gradient micropatterning technique is a groundbreaking advancement in sperm filtration for ART. By improving sperm selection efficiency, reducing sperm selection time, and enhancing fertilization rates, this method could revolutionize IVF outcomes. Its integration into ART centers worldwide could lead to better success rates and more accessible fertility treatments for patients, offering hope to many individuals and couples seeking to build families.
As further research validates and refines this technique, the future of assisted reproduction looks even brighter, with more precision and better outcomes on the horizon.
We’re excited to share that SpOvum Technologies has been featured in a recent article on IndiaMedToday, a leading healthcare publication, for our groundbreaking collaboration with Khushi Fertility, led by Dr. Rashmi Yogish.
This feature highlights a first-of-its-kind partnership where SpOvum will take the lead in training and upskilling embryologists, ensuring standardised, high-quality practices across all Khushi Fertility centres. Through this strategic alliance, we aim to integrate our advanced Lab Management System (LMS), cutting-edge software, and proprietary hardware into their clinical ecosystem.
In the article, our Co-Founders Dr. Ramnath Babu T J (CEO) and Dr. Santosh Bhargav D B (CTO) shared their vision for building scalable, smart, and patient-centric IVF infrastructure in India. They emphasized how this collaboration will drive real-time R&D, accelerate innovation in AI-powered lab automation, and enhance embryologist performance and patient outcomes.
We’re proud to see our efforts recognised by IndiaMedToday and excited about the future this partnership is shaping for the fertility industry.
We were honored to be a part of the prestigious IHERA 2025 – 2nd International Conference on MicroEmb & ART 2.0, held on 24th and 25th May 2025 at The Park Hotel, Hyderabad. As one of the leading names in ART technology, SpOvum Technologies marked its presence not only as an exhibitor but also as a contributor to key scientific discussions shaping the future of human embryology.
Thought Leadership from the Founders
Our Co-Founders, Dr. Santosh Bhargav D B and Dr. Ramnath Babu T J, were invited as distinguished speakers at the event.
On 24th May, Dr. Santosh Bhargav D B, Co-Founder & CTO, presented an insightful talk titled “Role of Time-Lapse Monitoring in Fertilization Events.” In his session, he demonstrated how SpOvum’s AI-powered Time-Lapse Management Incubator is revolutionizing embryo assessment, offering clinicians deeper insights into fertilization dynamics and helping improve IVF outcomes.
On 25th May, Dr. Ramnath Babu T J, Co-Founder & CEO, delivered a visionary session on “ICSI – Robotics Redefining Micromanipulation.” He introduced RoboICSI, SpOvum’s groundbreaking robotic ICSI platform, showcasing how automation and precision engineering are setting new standards in micromanipulation procedures.
Engaging with the ART Community
SpOvum also hosted an engaging booth at the event, where ART professionals, embryologists, and clinic administrators experienced firsthand our range of smart ART technologies. Our team had the opportunity to connect, collaborate, and discuss practical challenges with the global fertility community.
IHERA 2025 was not just an event — it was a powerful reminder of how science, technology, and clinical practice can come together to shape the future of assisted reproduction. At SpOvum, we remain committed to pushing the boundaries of innovation and supporting fertility professionals with reliable, AI-integrated solutions.
Stay tuned as we continue our journey of enabling life through technology.
We are excited to share that Dr. Santosh Bhargav D B, Co-Founder and CTO of SpOvum Technologies, has been featured in the esteemed E-Health Magazine — a leading voice in the healthcare industry.
In his expert column, Dr. Santosh highlights the growing importance of Lab Management Systems (LMS) in ensuring data consistency across IVF clinics. With increasing demands for accuracy and regulatory compliance in Assisted Reproductive Technology (ART), Dr. Santosh shares how LMS platforms can revolutionise the way fertility labs manage samples, treatment records, and clinical processes.
From automated sample tracking to centralised data storage and role-based access control, the article offers practical insights on how the right technology can drive efficiency, reduce errors, and support better patient outcomes.
We’re proud to see our thought leadership recognised in the healthcare space, and we remain committed to building innovative tech solutions for IVF and fertility care.
We are thrilled to share that our Co-founder and CEO, Dr. Ramnath Babu T J, has been featured in BW Healthcare World with his insightful article on AI and automation in the Indian IVF industry.
AI & Automation: The Future of Indian IVF
With infertility affecting nearly 17.5% of the global population, the demand for Assisted Reproductive Technologies (ART) is on the rise. Dr. Ramnath Babu’s article highlights how AI-driven innovations are revolutionizing IVF procedures by enhancing embryo selection, improving success rates, and personalizing treatment.
India’s Push for AI in Healthcare
The Indian government’s IndiaAI Mission, a $1.25 billion initiative, aims to integrate AI across industries, including reproductive medicine. With regulations like the ART Regulation Bill, India is moving towards a standardized, ethical, and technology-driven IVF landscape.
Spreading Awareness & Adoption
Despite advancements, lack of awareness remains a major challenge. Fertility centers, including those supported by SpOvum, are leveraging digital outreach and AI-driven solutions to educate couples and streamline treatments.
Overcoming Challenges, Embracing Opportunities
While concerns like affordability, infrastructure, and ethical AI use persist, the future looks promising. AI has the potential to make IVF more efficient, affordable, and accessible, turning challenges into opportunities for aspiring parents.
We at SpOvum Technologies are committed to driving this transformation, supporting IVF clinics with innovative tech solutions. Read the full article on BW Healthcare World to explore how AI is shaping the future of fertility treatments.
We are proud to announce that SpOvum Technologies has been featured in the Indian Institute of Science (IISc) Research News for our groundbreaking contributions to IVF and Assisted Reproductive Technology (ART). The article highlights our commitment to improving IVF success rates through advanced robotics and AI-driven solutions.
One of the key innovations covered in the feature is ROBO-ICSI, an automated system designed to enhance intracytoplasmic sperm injection (ICSI). Unlike traditional methods that require highly skilled embryologists to manually handle delicate procedures, ROBO-ICSI uses a robotic gripper to hold the oocyte (egg cell) with precision, reducing the risk of damage and improving fertilization outcomes.
Our Co-Founder and CEO, Dr. Ramnath Babu T J, shared insights on the critical need for data-driven and automation-based solutions in ART. With current IVF success rates averaging between 30-40%, SpOvum is focused on bridging the gap through innovations such as AI-assisted embryo selection, computer-aided semen analysis (CASA), and real-time monitoring systems to help clinicians make better-informed decisions.
The article also discusses how emerging technologies like electronic witnessing and AI-powered embryo evaluation are transforming fertility care, ensuring accuracy, reducing errors, and enhancing patient outcomes.
We are honored to be recognized by IISc for our contributions to reshaping the future of reproductive healthcare. Read the full feature here to explore how technology is driving the next phase of IVF advancements.
SpOvum Technologies proudly participated in ISAR 2025, Lucknow, showcasing groundbreaking advancements in Assisted Reproductive Technology (ART). From launching new products to engaging with industry experts, our presence at ISAR was all about innovation, collaboration, and the future of fertility technology.
Key Highlights from ISAR 2025
✔ WhatsApp Bot for Instant Product Insights Visitors at our booth engaged with SpOvum’s WhatsApp Bot, scanning the QR code to instantly receive detailed insights about our latest products. This seamless experience helped professionals explore our cutting-edge ART solutions effortlessly.
✔ Exciting Product Launches & Showcases SpOvum introduced several game-changing ART innovations, including: – Time Lapse Monitoring (TLM) – Revolutionizing embryo observation and incubation. – Lab Management System (LMS) – Optimizing lab workflows and efficiency. – Smart Alert & Smart Witness – IoT-powered lab monitoring for accuracy and security. – ART Dashboard & ART-GPT – AI-driven solutions for intelligent fertility care.
✔ Leadership in Action: The Future of ICSI Innovation Our Director, Dr. Ramnath Babu T J, delivered an insightful talk on “The Robotic Revolution: Where do we stand in ICSI innovation?” addressing the role of robotics in enhancing intracytoplasmic sperm injection (ICSI).
✔ Engaging Booth Experience SpOvum’s booth became a hub of innovation and interaction, drawing attention with our cutting-edge ART products. Our team actively engaged with fertility specialists, embryologists, and industry leaders, sharing how SpOvum is shaping the future of reproductive technology.
Looking Ahead
ISAR 2025 was a remarkable platform to showcase SpOvum’s commitment to ART innovation. We look forward to continuing our journey in transforming fertility care with AI, automation, and data-driven insights.
At SpOvum, we are committed to making information about our cutting-edge A.R.T. solutions easily accessible. To enhance your experience, we’ve introduced a WhatsApp Bot designed specifically for ISAR 2025 attendees and beyond. With just a simple scan, you can receive instant details about our products, including key features, brochures, and specifications—right at your fingertips!
How to Use the WhatsApp Bot in 3 Easy Steps
Step 1: Scan the QR Code & Start Chat Open your phone’s camera, scan the QR code provided at our booth, and initiate a WhatsApp chat.
Step 2: Send the Message The bot will automatically generate the message: “Hello SpOvum, from ISAR 2025!” Simply hit send to begin.
Step 3: Select a Product A list of SpOvum’s innovative A.R.T. solutions will appear. Choose any product to receive detailed information instantly.
Why Use the SpOvum WhatsApp Bot?
✅ Instant access to product details and brochures ✅ Hassle-free navigation—no need to browse multiple pages ✅ Available anytime, anywhere for quick reference
Experience the future of A.R.T. technology with SpOvum—scan, send, and explore!